TABEX

Medicinal product

(Invented) name

TABEX

Active substance (s)

Citisiniklinas

Strength

1,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07BA04, cytisinicline

Marketing authorisation holder

UAB TBS Pharma, Lietuva

Date of authorisation

2024-03-14

Date of renewal

Documents

2119_TABEX 1,5mg_pl_deng_tab_PZPL_2024-03-14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Citisiniklinas	1,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113188	99307	1099307	lizdinė plokštelė	N100 (5x20)		Nereceptinis	LT/L/24/2119/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-03-14	Registruotas